SartoreG, ChilelliNC, BurlinaS, LapollaA: Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes. Acta Diabetol, 2013; 50:437–442.
2.
BragdJ, AdamsonU, BäcklundLB, LinsPE, MobergE, OskarssonP: Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?. Diabetes Metab, 2008; 34:612–616.
3.
ServiceFJ, MolnarGD, RosevearJW, AckermanE, GatewoodLC, TaylorWF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes, 1970; 19:644–655.
4.
MonnierL, MasE, GinetC, MichelF, VillonL, CristolJP, ColetteC: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA, 2006; 295:1681–1687.
HillNR, OliverNS, ChoudharyP, LevyJC, HindmarshP, MatthewsDR: Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther, 2011; 13:921–928.
7.
BaghurstPA: Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm. Diabetes Technol Ther, 2011; 13:296–302.
8.
FritzscheG, KohnertKD, HeinkeP, VogtL, SalzsiederE: The use of a computer program to calculate the mean amplitude of glycemic excursions. Diabetes Technol Ther, 2011; 13:319–325.
